Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-06

Clinical Trial Update: Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether pretreatment with intravenous nicorandil reduces contrast-induced nephropathy in patients with chronic kidney disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicorandil (nicorandil)

Snippet

Sponsor: Yonsei University | Conditions: Chronic Renal Failure | Phase 4 | Status: COMPLETED